Stocks Listing
NOVN.SW

Novartis AG

Share
NOVN.SW
$84.63 0.42%Last Updated Oct 03 2022 03:17 PM
1D Low / 1D High
Low:$83.38
High:$85.12
1D
0.42%
5D
1.95 %
30D
4.55 %
BulletPurple
Market Cap
$184,728,683,467
0.41 %
184.7 B
BulletBlue
Volume 1D
2,003,399
-
2 M
BulletOrange
Circulating Supply
2,182,789,725 NOVN.SW
2.2 B

Price Chart

1D
5D
1M
6M
YTD
1Y
MAX
About

Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology and dermatology, respiratory, established, and cardiovascular, renal and metabolism medicine products. The Sandoz segment provides active ingredients and finished dosage forms of small molecule pharmaceuticals to third parties across a range of therapeutic areas, as well as finished dosage form anti-infectives. It also provides active pharmaceutical ingredients and intermediates primarily antibiotics; protein- or other biotechnology-based products, including biosimilars; and biotechnology manufacturing services. Novartis AG has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran; an agreement with CureVac to manufacture COVID-19 vaccine candidate CVnCoV; a collaboration with Artios Pharma Limited to create next generation DDR cancer therapies; and a clinical collaboration with Kura Oncology, Inc. to evaluate the combination of Tipifarnib and Alpelisib in patients with head and neck squamous cell carcinoma. The company was incorporated in 1996 and is headquartered in Basel, Switzerland.

Read More

Historical data

1D
5D
1M
6M
1Y
MAX
Day
Open - Close
Low/High
Volume
Market Cap
Show More
Market Status
Closed
EBS
Swiss Stock Exchange
CHE
Opens in
9 hours, 7 minutes
Working Hours
Mon-Fri, 07:00 AM - 03:20 PM
Timezone
GMT+0